Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains

• Published in: Vaccine 2010-10, Vol.28 (42), p.6852-6857
• Main Authors: Lee, Vernon J, Tay, Joshua K, Chen, Mark I.C, Phoon, M.C, Xie, M.L, Wu, Y, Lee, Cynthia X.X, Yap, Jonathan, Sakharkar, K.R, Sakharkar, M.K, Lin, Raymond T, Cui, Lin, Kelly, Paul M, Leo, Yee Sin, Tan, Yee Joo, Chow, Vincent T.K
• Format: Article
• Language: English
• Subjects: 2009 pandemic; Adult; Allergy and Immunology; Antibodies, Neutralizing - blood; Antibodies, Viral - blood; Antibody Formation; Applied microbiology; B-cell epitopes; Biological and medical sciences; Cross Protection; Cross Reactions; Cross-reactive neutralizing antibodies; Epitopes, B-Lymphocyte - immunology; Fundamental and applied biological sciences. Psychology; Humans; Immunization; Influenza A H1N1; Influenza A Virus, H1N1 Subtype - immunology; Influenza Vaccines - immunology; Influenza, Human - immunology; Influenza, Human - prevention & control; Male; Microbiology; Middle Aged; Miscellaneous; Mortality; Neutralization Tests; Pandemics; Prospective Studies; Seasonal influenza vaccine; Studies; Swine flu; Vaccines; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects); Vaccines, Inactivated - immunology; Virology; Viruses; Young Adult
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2010.08.031

Abstract Background In June 2009, we conducted a prospective study in Singapore on 51 individuals to determine their serologic responses before and following receipt of the 2009 Southern Hemisphere seasonal influenza vaccine. Materials and methods Paired serum samples were obtained before and 3–4 weeks after vaccination. Virus microneutralization assays were performed to quantify antibodies against A/Brisbane/59/2007 vaccine, pandemic H1N1-2009 and A/Puerto Rico/08/34 H1N1 strains. Results Post-vaccination, 43%, 12% and 24% of subjects displayed a 4-fold or greater rise in neutralizing antibody titers against the three strains, respectively. There was a positive correlation among individuals who showed increased titers to both pandemic H1N1-2009 and A/Puerto Rico/08/34 ( p < 0.001). However, this correlation was not observed for A/Brisbane/59/2007 with either strain. The relative conservation and accessibility of predicted B-cell epitopes may explain the limited cross-reactivity of the antibodies directed against common H1N1 epitopes. Conclusions These results suggest that seasonal influenza vaccination confers a certain degree of cross-protection to other H1N1 strains. The correlation in cross-reactive antibody titers to A/Puerto Rico/08/34 and pandemic H1N1-2009 implies that previous exposure to pre-1957 H1N1 strains may confer some protection against the 2009 pandemic strain.